Adedayo A. Onitilo

Also affiliated with University of Wisconsin–Madison, Marshfield Clinic Weston Center, Marshfield Clinic

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile

0.221Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Cancer Research Funding in Africa

Communications Medicine(2025)10.1038/s43856-025-00992-7

Top 63%

0.221DataRank

Top 63%2 citations

Elise M. Garton, Olaoluwa Ezekiel Dada, Sehar Salim Virani, Abdul R. Shour, Adedayo A. Onitilo +2 more

Papers

Driven by 18 papers — median percentile 37. Top paper: “Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma”.

Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma

New England Journal of Medicine(2023)10.1056/nejmoa2211437

N/A

6.5DataRank · unranked

846 citations

Megan Othus, Yuanbin Chen, G. Paul Wright, Kathleen J. Yost, John Hyngstrom +48 more

Evaluating the association of frailty with communication about aging‐related concerns between older patients with advanced cancer and their oncologists

Cancer(2021)10.1002/cncr.34010

N/A

0.854DataRank · unranked

17 citations

Huiwen Xu, Lee Kehoe, Amber S. Kleckner, Kiran Moorthi, Lianlian Lei +16 more

A randomized study of genetic education versus usual care in tumor profiling for advanced cancer in the ECOG‐ACRIN Cancer Research Group (EAQ152)

Cancer(2021)10.1002/cncr.34063

N/A

0.616DataRank · unranked

15 citations

Ju‐Whei Lee, Jill B. Gaieski, Shuli Li, Ilana F. Gareen, Keith T. Flaherty +15 more

The association between cancer-related fatigue and diabetes from pre-chemotherapy to 6 months post-chemotherapy

Supportive Care in Cancer(2022)10.1007/s00520-022-07189-x

N/A

0.579DataRank · unranked

14 citations

Ian R. Kleckner, Eva Culakova, Michelle Shayne, Elizabeth Belcher, Abdi T. Gudina +8 more

Dual anti-CTLA-4 and anti-PD-1 blockade in metastatic basal cell carcinoma

npj Precision Oncology(2025)10.1038/s41698-024-00798-1

N/A

0.303DataRank · unranked

5 citations

Eleanor Cano-Linson, Young Kwang Chae, Shiruyeh Schokrpur, Christopher D. Lao, Benjamin Powers +13 more

Olanzapine With or Without Fosaprepitant for Preventing Chemotherapy Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial (ALLIANCE A221602)

The Oncologist(2023)10.1093/oncolo/oyad140

N/A

0.229DataRank · unranked

3 citations

Jennifer Le‐Rademacher, Fabrice Smieliauskas, Kathryn J. Ruddy, Thomas J. Saphner, Heshan Liu +10 more

Cancer Research Funding in Africa

Communications Medicine(2025)10.1038/s43856-025-00992-7

Top 63%

0.221DataRank

Top 63%2 citations

Elise M. Garton, Olaoluwa Ezekiel Dada, Sehar Salim Virani, Abdul R. Shour, Adedayo A. Onitilo +2 more

Phase II Study of Palbociclib in Patients with Tumors with CDK4 or CDK6 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1C

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0036

N/A

0DataRank · unranked

8 citations

Opeyemi A. Jegede, Mark A. Dickson, Angela DeMichele, Richard Piekarz, Robert J. Gray +15 more

Importance of information-seeking styles among patients with cancer pre- and post-treatment: A URCC NCORP Research Base study.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.1527

N/A

0DataRank · unranked

1 citations

Supriya G. Mohile, David Adler, Ronald M. Epstein, Kah Poh Loh, Annette Medina‐Walpole +15 more

Inhibition of FOXM1 synergizes with BCL2 inhibitor Venetoclax in killing non-t(11;14) multiple myeloma cells via repressing MYC pathway

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.09.27.613548

N/A

0DataRank · unranked

0 citations

Siegfried Janz, Yidan Wang, Benita S. Katzenellenbogen, John A. Katzenellenbogen, Sung Hoon Kim +2 more

Randomized trial of web-based genetic education versus usual care in advanced cancer patients undergoing tumor genetic testing: Results from the ECOG-ACRIN NCI Community Oncology Research Program (NCORP; EAQ152) COMET trial.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2008

N/A

0DataRank · unranked

0 citations

Ju‐Whei Lee, Jill B. Gaieski, Shuli Li, Ilana F. Gareen, Keith T. Flaherty +15 more

Inhibition of FOXM1 Synergizes with BH3 Mimetics Venetoclax and Sonrotoclax in Killing Multiple Myeloma Cells through Repressing MYC Pathway

Advanced Science(2025)10.1002/advs.202508822

N/A

0DataRank · unranked

3 citations

Yidan Wang, Kathryn Fox, Adam Bissonnette, Luke F. Moat, Terrie Kitchner +12 more

Reply to The effects of curative‐intent cancer therapy on employment, work ability, and work limitations

Cancer(2021)10.1002/cncr.33566

N/A

0DataRank · unranked

0 citations

Kris Kwekkeboom, Kevin A. Buhr, Alexandra Dennee, William R. Conkright, Adedayo A. Onitilo +10 more

Prognostic understanding, hospitalization, and hospice use among older patients with advanced cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.12037

N/A

0DataRank · unranked

0 citations

Christopher L. Seplaki, Reza Yousefi Nooraie, Jennifer L. Lund, Ronald M. Epstein, Paul R. Duberstein +14 more

Association of polypharmacy and potential drug-drug interactions with adverse outcomes in older adults with advanced cancer receiving systemic treatment.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.12053

N/A

0DataRank · unranked

1 citations

Supriya G. Mohile, Katherine M. Juba, Hala Awad, Megan Wells, Kah Poh Loh +8 more

Olanzapine with or without an NK-1 receptor antagonist for preventing chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy: A phase III randomized, double-blind, placebo-controlled trial (ALLIANCE A221602).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.12107

N/A

0DataRank · unranked

1 citations

Jennifer Le‐Rademacher, Fabrice Smieliauskas, Kathryn J. Ruddy, Thomas J. Saphner, Heshan Liu +9 more

Association of nutrition with psychological health and quality of life among older adults with advanced cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.12043

N/A

0DataRank · unranked

1 citations

Zhaoyang Qin, Derick R. Peterson, Richard F. Dunne, Ying Wang, Eva Culakova +7 more

Peaceful acceptance of illness among older adults with cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.12045

N/A

0DataRank · unranked

0 citations

S. Hryniv, William Consagra, Supriya G. Mohile, Sule Yilmaz, Eva Culakova +10 more

Adedayo A. Onitilo

Indexed papers

Top data-sharing exemplar

Papers